SCHEMBL6410185

SCHEMBL6410185

O=Cc1ccc(CO)n1CCCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.44
FABP5 Q01469 3/20 0.44
HSD17B10 Q99714 3/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPK1 P28482 2/20 0.37
HDAC3 O15379 1/20 0.36
ADRA1A P35348 1/20 0.36
HDAC4 P56524 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11875254 0.79 RXRA (0.45) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL11562036 0.68 TRIM24 (0.43) FABP4FABP5MAPK1HDAC3ADRA1A
SCHEMBL411981 0.63 APEX1 (0.54) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL4314440 0.61 FABP4 (1.00) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL30573159 0.61 FABP4 (1.00) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL29954757 0.60 TRIM24 (0.46) FABP4FABP5SMN1; SMN2MAPTMEN1
SCHEMBL5170220 0.60 FABP4 (0.56) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL7344985 0.59 KDM4E (0.49) FABP4FABP5HSD17B10KDM4EMAPK1
SCHEMBL29129893 0.59 SMN1; SMN2 (0.69) HSD17B10MAPK1HDAC3ADRA1AHDAC4
SCHEMBL25465028 0.58 PTGS1 (0.53) FABP4FABP5MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4193862-A None JP disclosed
CN-118806826-A A tea for resolving hard mass and its preparation method 佛山市人铁智谷大药房有限公司 2024-10-22 CN disclosed
CN-117865945-A 2-aldehyde pyrrole butyric acid derivative, preparation method and application thereof 天津现代创新中药科技有限公司 2024-04-12 CN disclosed
US-20200385347-A1 PYRROLE COMPOUND MYCOLOGY TECHNO.CORP. (JP) 2020-12-10 US disclosed
US-20200385347-A1 PYRROLE COMPOUND MYCOLOGY TECHNO.CORP. (JP) 2020-12-10 US disclosed
CN-103073479-B Method for preparing natural pyrrole derivative from plant brassica rapa L. by extraction, purification and separation UNIV SICHUAN 2015-02-04 CN disclosed
CN-103073479-A Method for preparing natural pyrrole derivative from plant brassica rapa L. by extraction, purification and separation UNIV SICHUAN 2013-05-01 CN disclosed
US-20050163801-A1 Method of inducing apoptosis and compositions therefor KYOWA ENGINEERING CO., LTD. (JP) 2005-07-28 US disclosed
EP-1454626-A1 METHOD OF INDUCING APOPTOSIS AND COMPOSITIONS THEREFOR Sundory Co., Ltd. (JP) 2004-09-08 EP disclosed
JP-H04193862-A 4-(2-FORMYL-5-HYDROXYMETHYL-PYRROL-1-YL)BUTYRIC ACID AND TASTE AND FLAVOR-IMPROVING AGENT FOR TABACCO COMPOSED THEREOF JAPAN TOBACCO INC 1992-07-13 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050163801-A1 Method of inducing apoptosis and compositions therefor TREH, ACIN1, WAPL FABP4 692/4885FABP5 2611/4885HSD17B10 2522/4885
US-20200385347-A1 PYRROLE COMPOUND PYCR1, ALDH18A1, FKBP1B FABP4 2657/4885FABP5 2289/4885HSD17B10 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.